Microsaic Systems plc Agreement with Rightek Co., Ltd. (4127N)
09 May 2018 - 4:01PM
UK Regulatory
TIDMMSYS
RNS Number : 4127N
Microsaic Systems plc
09 May 2018
9 May 2018
Microsaic Systems plc
("Microsaic"or the "Company")
Agreement with Rightek Co., Ltd.
Microsaic Systems plc (AIM: MSYS), the developer of point of
need mass spectrometry ("MS") instruments, is pleased to announce
that it has signed an agreement with Rightek Co., Ltd. ("Rightek")
(the "Agreement").
The Agreement covers the distribution of Microsaic's 4500 MiD(R)
mass spectrometry detector via Rightek's distribution network in
Taiwan.
Glenn Tracey, CEO of Microsaic, commented, "This agreement with
Rightek further consolidates our strategy to extend the sales of
our unique compact, point of need technology into the Asia Pacific
area.
Rightek combines expertise in understanding end-user
applications, together with a proven track record of working with a
wide range of specialised scientific instrumentation.
This agreement is in line with our strategy to partner with
locally based and established channel partners, with expertise in
selling innovative analytical instrumentation to progressive
end-users in process and pharmaceutical markets."
Moses Shih, General Manager of Rightek, added "Rightek is
committed to helping our customers achieve success, to solve their
problems by finding suitable high-quality technologies to meet ever
challenging demands. We believe that Microsaic's compact,
point-of-need systems can improve the efficiencies by optimizing
the process in chemical and pharma industries."
Enquiries:
Microsaic Systems plc
Glenn Tracey, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser
& Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
IFC Advisory Ltd (Financial
PR)
Graham Herring
Heather Armstrong
Florence Chandler +44 (0)20 3934 6630
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company
developing chip-based, bench-top and point-of-analysis mass
spectrometry ("MS") instruments that are designed to improve the
efficiency of pharmaceutical R&D and manufacturing. The Company
is working with established global life science companies to
co-develop new solutions to improve productivity in the development
of small molecule and novel biologic (peptides, antibodies)
medicines. MS is a powerful method of analysis to enable earlier
decision making relating to product identification, purity and
bioactivity, and is the analytical technique of choice for
biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD(R), is a robust and
compact MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. For more
information, please go to www.microsaic.com.
About Rightek Co., Ltd
Established in December 2007, Rightek is headquartered in Wujin
District, New Taipei City, and also has offices in Taichung and
Kaohsiung. Rightek distributes a wide range of scientific equipment
through its Analytical, Synthesis and Process Equipment
divisions.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGREASSPELEPEFF
(END) Dow Jones Newswires
May 09, 2018 02:01 ET (06:01 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024